No global increase in resistance to antibiotics: a snapshot of resistance from 2001 to 2016 in Marseille, France.
Antibiotic resistance
Epidemiology
Marseille
Snapshot
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Feb 2019
Feb 2019
Historique:
received:
08
08
2018
accepted:
21
11
2018
pubmed:
6
12
2018
medline:
6
5
2019
entrez:
6
12
2018
Statut:
ppublish
Résumé
Since effective empirical antibiotic therapy is a key factor for survival, local antibiotic resistance epidemiology is critical. We aimed to identify current trends in antibiotic resistance for key antibiotics obtained over 16 years (2001-2016) for invasive infections corresponding to empirical treatment in a large hospital centre in Marseille, France.From January 2014 to December 2016, we have collected all data on antibiotic susceptibility from public laboratory hospitals, and a retrospective analysis was performed on key antibiotics in blood cultures since 2001. A total of 99,932 antibiotic susceptibility testings (ASTs) were analysed, and proportion of pan-drug resistant (PDR = resistant to all antibiotics tested) and extensively drug-resistant (XDR = resistant to all except for two classes) strains were < 0.03 and 0.5%, respectively. Between 2001 and 2016, we found an increase of resistance to third-generation cephalosporins for E. coli invasive strains (0% vs 17.8%; p < 10
Identifiants
pubmed: 30515637
doi: 10.1007/s10096-018-3439-8
pii: 10.1007/s10096-018-3439-8
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Comparative Study
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
395-407Références
J Mol Evol. 2004 Jul;59(1):133-41
pubmed: 15383916
Clin Microbiol Infect. 2010 Dec;16(12):1699-701
pubmed: 20874758
Future Microbiol. 2010 Nov;5(11):1733-54
pubmed: 21133692
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Emerg Infect Dis. 2011 Oct;17(10):1791-8
pubmed: 22000347
Front Microbiol. 2013 Jun 24;4:173
pubmed: 23805136
J Clin Microbiol. 2013 Nov;51(11):3780-7
pubmed: 24006011
Clin Microbiol Infect. 2014 Apr;20(4):O255-66
pubmed: 24131428
Clin Microbiol Infect. 2014 Sep;20(9):821-30
pubmed: 24930781
Emerg Infect Dis. 2014 Jul;20(7):1170-5
pubmed: 24959688
Int J Antimicrob Agents. 2015 Jan;45(1):61-5
pubmed: 25455851
Lancet Infect Dis. 2015 Apr;15(4):475-85
pubmed: 25716293
Clin Microbiol Infect. 2015 Jun;21(6):515-7
pubmed: 25941171
Emerg Infect Dis. 2015 Aug;21(8):1302-10
pubmed: 26196165
New Microbes New Infect. 2015 Jul 10;7:89-93
pubmed: 26442150
Int J Antimicrob Agents. 2015 Dec;46(6):718-20
pubmed: 26589488
Lancet Infect Dis. 2016 Feb;16(2):161-8
pubmed: 26603172
Nature. 2016 Mar 10;531(7593):249-52
pubmed: 26934229
Clin Microbiol Infect. 2016 May;22(5):408-15
pubmed: 27021418
Int J Antimicrob Agents. 2016 Apr;47(4):249
pubmed: 27026226
Int J Antimicrob Agents. 2017 Jan;49(1):98-101
pubmed: 27887966
PLoS Med. 2016 Nov 29;13(11):e1002184
pubmed: 27898664
Emerg Infect Dis. 2017 Apr;23(4):582-589
pubmed: 28322712
Nature. 2017 May 3;545(7652):23-25
pubmed: 28470219
Lancet Infect Dis. 2017 Jul;17(7):690
pubmed: 28653629
Clin Infect Dis. 2017 Aug 15;65(suppl_1):S58-S63
pubmed: 28859341
Clin Microbiol Infect. 2018 Sep;24(9):935-943
pubmed: 29605563
Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1687-1697
pubmed: 29956024
J Antimicrob Chemother. 2018 Sep 1;73(9):2503-2509
pubmed: 29982514
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683